Results for
"[search-keyword]"
Sponsor content
49 result(s) found, displaying 11 to 20
-
-
Prescription medicine decision summarySohonos (palovarotene) is approved to reduce the formation of heterotopic ossification.
-
-
FORLAX macrogol 4000 10g powder for oral solution sachet Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Ipsen Pty Ltd -
Oct-2023Prescription medicine evaluationActive ingredient: odevixibat, odevixibat sesquihydrate.
-
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
Prescription medicine registrationActive ingredients: triptorelin embonate.